Search
for
Sort by
Research 571–600 of 1000+
- Botulinum Toxin A for Hair Loss Treatment: A Systematic Review of Efficacy, Safety, and Future Directions
- mTOR signaling in hair follicle and hair diseases: recent progress
- Peer Review Report For: Pattern changes of cutaneous dermatoses among Iraqi women preceding and during the COVID-19 pandemic [version 3; peer review: 2 approved]
- Pattern changes of cutaneous dermatoses among Iraqi women preceding and during the COVID-19 pandemic
- The Non-Cosmetic Dermatological Use of Botulinum Neurotoxin
- Referee report. For: Pattern changes of cutaneous dermatoses among Iraqi women preceding and during the COVID-19 pandemic [version 2; peer review: 1 approved]
- Hair Loss in Children, Etiologies, and Treatment
- Dermatologic manifestations of thyroid disease: a literature review
- The JAK/STAT signaling pathway: from bench to clinic
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- The use of cyclosporine in dermatology: Part I
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Local heroes or villains: tissue-resident memory T cells in human health and disease
- The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review
- <i>In vivo </i>CD44‐CD49d complex formation in autoimmune disease has consequences on T cell activation and apoptosis resistance
- Diverse Role of OX40 on T Cells as a Therapeutic Target for Skin Diseases
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Under Development JAK Inhibitors for Dermatologic Diseases
- Use of an Alternating Inflatable Head Pad inPatients Undergoing Open Heart Surgery
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Post-partum pituitary insufficiency and livedo reticularis presenting a diagnostic challenge in a resource limited setting in Tanzania: a case report, clinical discussion and brief review of existing literature